Published date: 7 May 2020

This notice was replaced on 3 August 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 3 August 2020)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Various medicinal products - 33690000

Location of contract

North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West, Isle of Man, Channel Islands

Value of contract

£4,331,506

Procurement reference

tender_239488/852383

Published date

7 May 2020

Closing date

20 May 2020

Contract start date

1 August 2020

Contract end date

31 July 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

This is an accelerated procedure.

Justification

The COVID-19 outbreak has given rise to an urgent need for the supply of certain generic hospital only medicines where suppliers have terminated or previous tenders have been unable to secure supply, to avoid NHS resources being diverted to source alternative products and ensure continuity. This does not give sufficient time to comply with the standard open procedure timescales for this procurement. The Commercial Medicines Unit considers this to be a state of urgency which it has duly substantiated. Accordingly, the Commercial Medicines Unit is using the accelerated time limits permitted under the Public Contract Regulations 2015 (regulation [27(5) for the open in respect of this procurement.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS National Framework Agreement for the Supply of Generic Pharmaceuticals - Interim 1 2020
Offer reference number: CM/PHG/20/5589
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the Authority's sole discretion) for up to a further 12 months)
Potential periods of call-offs under the framework agreement
Hospital Only Products:
DLS/DNE/DNW 01/08/2020 to 31/07/2021 (12 months)
DLN/DCE/DSW 01/08/2020 to 31/07/2021 (12 months)

More information

Attachments

Links

About the buyer

Contact name

David Ford

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

david.ford1@nhs.net